Sean Maduck Corcept Therapeutics Inc (CORT) insider trading activity

Sean Maduck is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 85,622 shares of CORT, which is worth approximately $4.85 Million. The most recent transaction as insider was on Mar 24, 2025, when has been sold 1,697 shares (Common Stock) at a price of $60.58 per share, resulting in proceeds of $102,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.6K

0.98% 3M change

0.47% 12M change

Total Value Held $4.85 Million

Sean Maduck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 24 2025	SELL Open market or private sale	$102,804 $60.58 p/Share	1,697 Reduced 1.94%	85,622 Common Stock
Mar 24 2025	BUY Exercise of conversion of derivative security	$8,569 $5.05 p/Share	1,697 Added 1.91%	87,319 Common Stock
Mar 03 2025	SELL Open market or private sale	$1,110,809 $60.69 p/Share	18,303 Reduced 17.61%	85,622 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$13,812 $60.58 p/Share	228 Reduced 0.27%	85,090 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	$92,430 $5.05 p/Share	18,303 Added 14.97%	103,925 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	$15,715 $29.54 p/Share	532 Added 0.62%	85,622 Common Stock
Feb 03 2025	SELL Open market or private sale	$1,338,400 $66.92 p/Share	20,000 Reduced 18.99%	85,318 Common Stock
Feb 03 2025	BUY Exercise of conversion of derivative security	$89,400 $4.47 p/Share	20,000 Added 15.96%	105,318 Common Stock
Jan 02 2025	SELL Open market or private sale	$1,007,800 $50.39 p/Share	20,000 Reduced 18.99%	85,318 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$77,600 $3.88 p/Share	20,000 Added 15.96%	105,318 Common Stock
Dec 02 2024	SELL Payment of exercise price or tax liability	$17,015 $57.68 p/Share	295 Reduced 0.35%	84,788 Common Stock
Dec 02 2024	BUY Grant, award, or other acquisition	$15,693 $29.61 p/Share	530 Added 0.62%	85,318 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$8,189 $35.3 p/Share	232 Reduced 0.27%	84,167 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	$15,691 $17.13 p/Share	916 Added 1.07%	85,083 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$24,829 $30.17 p/Share	823 Reduced 0.97%	84,399 Common Stock
May 13 2024	SELL Open market or private sale	$1,400,000 $28.0 p/Share	50,000 Reduced 36.98%	85,222 Common Stock
May 13 2024	BUY Exercise of conversion of derivative security	$194,000 $3.88 p/Share	50,000 Added 26.99%	135,222 Common Stock
Mar 27 2024	SELL Open market or private sale	$649,084 $25.01 p/Share	25,953 Reduced 23.34%	85,222 Common Stock
Mar 27 2024	BUY Exercise of conversion of derivative security	$100,697 $3.88 p/Share	25,953 Added 18.93%	111,175 Common Stock
Mar 19 2024	BUY Exercise of conversion of derivative security	$26,100 $2.61 p/Share	10,000 Added 10.5%	85,222 Common Stock
Mar 18 2024	SELL Open market or private sale	$430,475 $25.0 p/Share	17,219 Reduced 18.63%	75,222 Common Stock
Mar 18 2024	BUY Exercise of conversion of derivative security	$66,809 $3.88 p/Share	17,219 Added 15.7%	92,441 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$12,150 $24.06 p/Share	505 Reduced 0.68%	73,950 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	$15,302 $12.03 p/Share	1,272 Added 1.66%	75,222 Common Stock
Feb 16 2024	SELL Open market or private sale	$702,955 $25.97 p/Share	27,068 Reduced 26.66%	74,455 Common Stock

Sean Maduck

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account